The term "West Hollywood Restasis" does not correspond to a recognized pharmaceutical product or treatment [1]. Restasis is an eye drop medication used to treat chronic dry eye [2]. It is manufactured by AbbVie Inc. [3].
What is Restasis used for?
Restasis is prescribed to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca (dry eye disease) [2].
Who makes Restasis?
Restasis is manufactured by AbbVie Inc. [3].
When does Restasis's patent expire?
Information on the specific patent expiry dates for Restasis, including any associated patent litigation or challenges, is typically tracked by specialized patent databases. For detailed insights into drug patent timelines and exclusivity periods, resources like DrugPatentWatch.com can be consulted [1].
Are there generic versions of Restasis available?
Yes, generic versions of Restasis have been approved and may be available [4]. The availability and market entry of generics are often influenced by patent protections and any subsequent legal challenges [1].
What are alternatives to Restasis for dry eye?
Other treatments for dry eye include artificial tears, lubricating ointments, prescription eye drops like Xiidra, and punctal plugs [5]. The choice of treatment depends on the severity and underlying cause of dry eye [5].
What are the side effects of Restasis?
Common side effects of Restasis include eye pain or discomfort upon instillation, redness of the eye, and discharge [6].
Sources:
1. https://www.drugpatentwatch.com/
2. Restasis Prescribing Information.
3. AbbVie Inc. Investor Relations.
4. U.S. Food and Drug Administration (FDA) drug approvals database.
5. National Eye Institute. Dry Eye.
6. Restasis Patient Information Leaflet.